Sunscreen ingredient sits at the center of this dementia and brain health question.
The FDA has been investigating the safety of numerous chemical sunscreen ingredients for years, and as of the most recent regulatory updates, the agency still lacks sufficient data to classify most of them as “generally recognized as safe and effective.” Only two sunscreen ingredients — zinc oxide and titanium dioxide, both mineral-based filters — have received that full safety designation. The remaining dozen or so chemical UV filters commonly found on store shelves, including widely used compounds like avobenzone, homosalate, octinoxate, and oxybenzone, remain in a regulatory gray area where the FDA has requested additional testing from manufacturers but has not yet received all the evidence it needs to make a final call. For anyone caring for a loved one with dementia, where skin is often more fragile, medication interactions are common, and the person may not be able to communicate discomfort or reactions, understanding what is and isn’t settled science in sunscreen safety is especially important.
This matters beyond the medicine cabinet. Sunscreen use is a daily reality for dementia caregivers who take their loved ones outside for walks, garden time, or simply sitting on a porch — activities that research suggests support mood and cognitive engagement. But choosing the right sunscreen means navigating a confusing regulatory landscape where “FDA-approved” does not necessarily mean “FDA-verified as safe.” This article breaks down which ingredients are under scrutiny, what the absorption studies have shown, how this connects to brain health and dementia care, and what practical steps caregivers can take right now while the science catches up.
Table of Contents
- Which Sunscreen Ingredients Is the FDA Still Investigating for Safety?
- What Absorption Studies Revealed and Why the Results Are Not Conclusive
- The Oxybenzone Question and Endocrine Disruption Concerns
- Mineral Sunscreens vs. Chemical Sunscreens — What Caregivers Should Consider
- What the FDA’s Delay Means and Why Manufacturers Have Not Delivered Safety Data
- Sunscreen and Vitamin D — A Relevant Concern for Brain Health
- Where the Science and Regulation Are Heading
- Conclusion
- Frequently Asked Questions
Which Sunscreen Ingredients Is the FDA Still Investigating for Safety?
In a proposed rule that the FDA has been developing since 2019, the agency sorted sunscreen active ingredients into three categories. Category I includes zinc oxide and titanium dioxide — both deemed safe and effective. Category II includes two ingredients, PABA and trolamine salicylate, which the FDA considers not safe or not effective and which have largely disappeared from the market. Then there is Category III, the largest and most consequential group: twelve chemical UV filters for which the FDA says it needs more data before it can make a determination. This group includes oxybenzone, octinoxate (octyl methoxycinnamate), homosalate, octisalate, octocrylene, and avobenzone, among others. These are not banned.
They remain legal to sell. But the FDA has explicitly stated that existing safety data is insufficient. The reason this distinction matters is that FDA-funded absorption studies, published in journals like JAMA, demonstrated that several of these chemical filters enter the bloodstream at levels that exceed the FDA’s own threshold for requiring further toxicology testing. In one notable study, participants who applied sunscreen according to label directions showed plasma concentrations of oxybenzone that were hundreds of times above the threshold after just a single day of use. Absorption alone does not prove harm — that is a critical nuance — but it triggered the FDA’s request for additional safety studies, including tests for carcinogenicity, reproductive toxicity, and endocrine disruption. As of the most recent public information available, manufacturers had not fully delivered this data, and the rulemaking process remained incomplete.
What Absorption Studies Revealed and Why the Results Are Not Conclusive
The JAMA studies from 2019 and 2020 were pivotal in reshaping the sunscreen safety conversation. Researchers applied sunscreen to participants covering 75 percent of their body surface area — the amount recommended on most product labels — and measured blood levels of active ingredients over several days. Every chemical filter tested exceeded the 0.5 nanograms per milliliter threshold that the FDA uses to determine when further safety studies are warranted. Oxybenzone showed the highest absorption, reaching concentrations well above that threshold within hours. Homosalate and octocrylene also showed significant systemic absorption. However, exceeding the threshold does not mean these ingredients cause disease. The threshold is a regulatory trigger, not a danger line.
It simply means the FDA wants more information before it can confirm safety. This is an important distinction for caregivers who may read alarming headlines and feel pressured to stop using sunscreen entirely, which would be a worse health outcome given the well-established risks of UV exposure, including skin cancer. The limitation of the absorption studies is that they measured blood levels under maximum-use conditions and did not assess health outcomes. We do not yet have large-scale epidemiological data directly linking topical sunscreen chemical filters to specific diseases in humans at typical use levels. For dementia caregivers specifically, there is an additional wrinkle: many individuals with dementia take multiple medications, some of which increase photosensitivity. Certain antipsychotics, antidepressants, and even cholinesterase inhibitors can make skin more reactive to UV light. If the sunscreen being used to protect against that photosensitivity is itself being absorbed systemically, the potential for drug interactions — while unstudied in this specific context — is at least a reasonable concern to raise with a physician.
The Oxybenzone Question and Endocrine Disruption Concerns
Oxybenzone has drawn more scrutiny than any other sunscreen chemical, and for reason. Laboratory and animal studies have suggested it can act as an endocrine disruptor, mimicking estrogen and potentially interfering with hormone signaling. some epidemiological studies have found associations between oxybenzone exposure and altered hormone levels in adolescents, though these studies have significant limitations, including small sample sizes and difficulty controlling for confounding variables. Hawaii and Key West famously restricted the sale of sunscreens containing oxybenzone and octinoxate, primarily due to concerns about coral reef damage, but the human health questions contributed to public wariness. For the dementia care community, the endocrine disruption angle intersects with an active area of brain health research.
Hormonal changes, particularly drops in estrogen, have been studied as potential contributing factors in Alzheimer’s disease risk, especially in women. While no study has directly connected sunscreen-derived oxybenzone exposure to cognitive decline, the theoretical pathway — a compound that disrupts hormonal balance being absorbed into the bloodstream of an older adult already experiencing neurological vulnerability — is enough to warrant caution without warranting panic. The practical takeaway is not to fear sunscreen but to consider whether mineral alternatives might be a simpler choice for a population that already has enough pharmacological complexity. It is also worth noting that oxybenzone concentration in consumer sunscreens has historically ranged from about 2 to 6 percent, though some products went higher. The European Union has capped its concentration at lower levels than what has been permitted in the United States, reflecting a more precautionary regulatory stance that predates the FDA’s current investigation.
Mineral Sunscreens vs. Chemical Sunscreens — What Caregivers Should Consider
The simplest way to sidestep the open questions about chemical UV filters is to use mineral sunscreens containing zinc oxide, titanium dioxide, or both. These ingredients sit on the skin’s surface and physically block or scatter UV rays rather than absorbing them chemically. The FDA has classified both as safe and effective, and absorption studies show they do not enter the bloodstream in meaningful amounts. For dementia caregivers, mineral sunscreens have the additional advantage of being less likely to cause skin irritation or allergic reactions, which matters when the person you are caring for may not be able to tell you their skin is burning or itching. The tradeoff is cosmetic and practical.
Mineral sunscreens have historically been thicker, harder to rub in, and more likely to leave a white cast on skin — a problem that is more pronounced on darker skin tones. Newer formulations using micronized or nano-sized particles have improved this significantly, though some consumers and advocacy groups have raised separate questions about whether nanoparticle zinc oxide could penetrate damaged skin. Current evidence suggests that on intact skin, nanoparticle mineral sunscreens do not penetrate beyond the outermost layer, but for individuals with dementia who may have skin tears, pressure sores, or eczema, applying sunscreen to broken skin is inadvisable regardless of the formulation. Another consideration is application ease. Spray sunscreens are popular with caregivers because they are fast, but most spray formulations are chemical-based, and there are inhalation concerns, particularly for someone with dementia who may not understand to hold their breath or turn away. Mineral sunscreen sticks or lotions applied by hand, while slower, give the caregiver more control over coverage and avoid respiratory exposure.
What the FDA’s Delay Means and Why Manufacturers Have Not Delivered Safety Data
The FDA’s sunscreen monograph reform has been one of the longest-running regulatory processes in the agency’s history. Sunscreen regulation in the United States operates under the monograph system rather than the new drug application process, meaning sunscreen ingredients were essentially grandfathered in decades ago based on limited evidence that would not meet modern standards. The Sunscreen Innovation Act of 2014 was supposed to accelerate the process, and the FDA’s 2019 proposed rule was a major step forward, but as of the most recent available information, the final rule had not been issued. One significant barrier is that the FDA asked manufacturers to conduct and submit the missing safety studies, but the industry has been slow to comply. These studies — including long-term carcinogenicity and developmental toxicity testing — are expensive and time-consuming, and manufacturers may have little financial incentive to fund research that could result in restrictions on their products.
This creates a frustrating catch-22 for consumers: the FDA cannot declare these ingredients safe without data, but the entities responsible for generating that data are the same ones who profit from the ingredients remaining on the market. Caregivers should understand that the absence of a final FDA ruling is not evidence of safety or danger — it is evidence of an incomplete process. The warning here is against overreaction in either direction. Abandoning sunscreen because of unresolved ingredient questions exposes vulnerable older adults to real, well-documented UV harm, including skin cancer and photoaging that can compromise already fragile skin. But blindly dismissing the open questions is also unwise, especially for a population with complex medication regimens and limited ability to self-advocate.
Sunscreen and Vitamin D — A Relevant Concern for Brain Health
One argument sometimes raised against rigorous sunscreen use, particularly in older adults, is that it may reduce vitamin D synthesis. Vitamin D deficiency has been associated in observational studies with increased risk of cognitive decline and dementia, though whether supplementing vitamin D actually prevents or slows dementia remains unproven.
In practice, most dermatologists and geriatricians note that typical sunscreen use does not completely block vitamin D production, and that dietary supplementation is a more reliable way to maintain adequate levels than relying on unprotected sun exposure, which carries its own serious risks. For caregivers, the practical approach is straightforward: use sunscreen when your loved one is outdoors, and discuss vitamin D supplementation with their physician. Trying to balance UV exposure for vitamin D against UV protection for skin cancer prevention is an imprecise and risky calculation, especially for someone who cannot monitor their own sun exposure or communicate when they have had enough.
Where the Science and Regulation Are Heading
The FDA’s sunscreen investigation is part of a broader global rethinking of cosmetic and personal care product regulation. The European Union, Australia, and other jurisdictions have approved newer UV filters — such as ecamsule (Mexoryl SX) and bemotrizinol (Tinosorb S) — that offer broad-spectrum protection and have more extensive safety data than some of the older filters still dominant in the U.S. market.
Advocacy groups and some dermatologists have pushed the FDA to create a faster pathway for approving these newer ingredients, which could eventually give American consumers, including dementia caregivers, more options that combine strong UV protection with better safety profiles. In the meantime, the most likely near-term outcome is that the FDA will finalize its monograph with zinc oxide and titanium dioxide confirmed as safe and effective, the two Category II ingredients removed, and the Category III ingredients remaining in a provisional status pending further data — or with conditions attached, such as concentration limits similar to those already adopted in Europe. For caregivers making decisions today, the safest practical path is to choose mineral-based sunscreens, apply them to intact skin, avoid sprays when possible, and continue prioritizing sun protection as a component of overall health management for the person in their care.
Conclusion
The FDA’s investigation into chemical sunscreen ingredients is not a cause for alarm, but it is a reason for informed decision-making — especially for those caring for people with dementia, whose skin may be more vulnerable, whose medication profiles are more complex, and whose ability to communicate reactions is diminished. The two mineral filters, zinc oxide and titanium dioxide, remain the only ingredients the FDA has fully endorsed as safe and effective. The dozen chemical filters still under review are not proven dangerous, but they have been shown to absorb into the bloodstream, and the long-term safety data the FDA has requested has not been fully provided.
Caregivers do not need to wait for the FDA to finish its process to make good choices now. Opting for mineral sunscreens, ensuring consistent application during outdoor time, discussing vitamin D supplementation and photosensitizing medications with a healthcare provider, and staying alert to skin reactions are all practical, evidence-based steps. Sun protection remains essential — the goal is not to avoid sunscreen but to choose it wisely while the regulatory picture continues to develop.
Frequently Asked Questions
Are chemical sunscreens dangerous?
They have not been proven dangerous, but the FDA has stated it does not have enough data to confirm they are safe. Key chemical filters like oxybenzone and homosalate have been shown to absorb into the bloodstream at levels that trigger the need for further safety testing. The absence of a final determination means the question remains genuinely open.
Is mineral sunscreen better for someone with dementia?
For most dementia caregiving situations, mineral sunscreen is the more straightforward choice. Zinc oxide and titanium dioxide have full FDA safety endorsement, are less likely to cause skin irritation, and do not absorb into the bloodstream. The main drawback is that they can be harder to apply evenly, but lotion and stick formats work well for caregiver-assisted application.
Does sunscreen block vitamin D production?
In real-world use, sunscreen reduces but does not eliminate vitamin D synthesis. However, relying on unprotected sun exposure for vitamin D is not recommended, especially for older adults at higher skin cancer risk. Supplementation, guided by a physician, is a safer and more reliable approach.
Should I stop using sunscreen until the FDA finishes its review?
No. The risks of unprotected UV exposure — including skin cancer, painful burns, and skin breakdown in fragile older skin — are well established and serious. The prudent approach is to switch to mineral-based sunscreens if you are concerned about chemical filters, not to abandon sun protection altogether.
Has oxybenzone been banned?
Oxybenzone has not been banned at the federal level in the United States. Hawaii and certain municipalities have restricted its sale in sunscreens, primarily due to environmental concerns about coral reef damage. The FDA continues to review its safety for human use and has not issued a ban.
You Might Also Like
- Why the FDA Is Cracking Down on Compounding Pharmacies
- The Medication Causing Birth Defects That Doctors Still Prescribe
- The Pre-Surgery Medication That Reduces Anxiety Better Than Midazolam
For more, see Alzheimer’s Association — medical tests.
